Multimodal Neuroimaging Insights into the Neurobiology of Healthy Aging Across the Lifespan

Overview

Journal Eur J Nucl Med Mol Imaging

Date 2025 Jan 31

PMID 39890633

Authors

Laust Vind Knudsen

Tanja Maria Michel

Ziba Ahangarani Farahani

Manouchehr Seyedi Vafaee

Affiliations

Soon will be listed here.

Abstract

Purpose: The purpose of this study was to advance our understanding of the neurobiology of healthy aging, which is crucial for improving quality of life and preventing age-related diseases. Despite its importance, a comprehensive investigation of this process has yet to be fully characterized.

Methods: We used a hybrid PET/MRI scanner to assess neurophysiological parameters in 80 healthy individuals aged 20-78. Cerebral amyloid-beta (Aβ) deposition and glucose metabolism were assessed using PET scans, while participants underwent simultaneous MRI scans.

Results: We found a positive correlation between Aβ-deposition and aging, and a negative correlation between glucose metabolism and aging. The insula showed the strongest negative correlation between glucose metabolism and age (Spearman's r = -0.683, 95% CI [-0.79, -0.54], p < 0.0001), while the posterior cingulate cortex had the strongest positive correlation between Aβ-deposition and age (Spearman's r = 0.479, 95% CI [0.28, 0.64], p < 0.0001). These results suggest a spatially dependent link between Aβ-deposition and metabolism in healthy older adults, indicating a compensatory mechanism in early Alzheimer's. Additionally, Aβ-deposition was linked to changes in interregional neural communication.

Conclusions: Our study confirms previous findings on aging and offers new insights, particularly on the role of Aβ-deposition in healthy aging. We observed a linear increase in Aβ-deposition, alongside decreases in white matter integrity, cerebral blood flow, and glucose metabolism. Additionally, we identified a complex regional relationship between Aβ-deposition, glucose metabolism, and neural communication, possibly reflecting compensatory mechanisms.

References

Raichle M, Gusnard D . Appraising the brain's energy budget. Proc Natl Acad Sci U S A. 2002; 99(16):10237-9. PMC: 124895. DOI: 10.1073/pnas.172399499. View

Binette A, Franzmeier N, Spotorno N, Ewers M, Brendel M, Biel D . Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer's disease. Nat Commun. 2022; 13(1):6635. PMC: 9636262. DOI: 10.1038/s41467-022-34129-4. View

Klunk W, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt D . Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004; 55(3):306-19. DOI: 10.1002/ana.20009. View

Mattsson N, Palmqvist S, Stomrud E, Vogel J, Hansson O . Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography. JAMA Neurol. 2019; 76(11):1319-1329. PMC: 6646987. DOI: 10.1001/jamaneurol.2019.2214. View

Zhao M, Mezue M, Segerdahl A, Okell T, Tracey I, Xiao Y . A systematic study of the sensitivity of partial volume correction methods for the quantification of perfusion from pseudo-continuous arterial spin labeling MRI. Neuroimage. 2017; 162:384-397. DOI: 10.1016/j.neuroimage.2017.08.072. View

Doucet G, Lee W, Frangou S . Evaluation of the spatial variability in the major resting-state networks across human brain functional atlases. Hum Brain Mapp. 2019; 40(15):4577-4587. PMC: 6771873. DOI: 10.1002/hbm.24722. View

Kakimoto A, Ito S, Okada H, Nishizawa S, Minoshima S, Ouchi Y . Age-Related Sex-Specific Changes in Brain Metabolism and Morphology. J Nucl Med. 2015; 57(2):221-5. DOI: 10.2967/jnumed.115.166439. View

Cohen A, Price J, Weissfeld L, James J, Rosario B, Bi W . Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. J Neurosci. 2009; 29(47):14770-8. PMC: 2810461. DOI: 10.1523/JNEUROSCI.3669-09.2009. View

Ashraf A, Fan Z, Brooks D, Edison P . Cortical hypermetabolism in MCI subjects: a compensatory mechanism?. Eur J Nucl Med Mol Imaging. 2014; 42(3):447-58. DOI: 10.1007/s00259-014-2919-z. View

10.

Croteau E, Castellano C, Fortier M, Bocti C, Fulop T, Paquet N . A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease. Exp Gerontol. 2017; 107:18-26. DOI: 10.1016/j.exger.2017.07.004. View

11.

Schultz A, Chhatwal J, Hedden T, Mormino E, Hanseeuw B, Sepulcre J . Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals. J Neurosci. 2017; 37(16):4323-4331. PMC: 5413178. DOI: 10.1523/JNEUROSCI.3263-16.2017. View

12.

Lawrence K, Nabulsi L, Santhalingam V, Abaryan Z, Villalon-Reina J, Nir T . Age and sex effects on advanced white matter microstructure measures in 15,628 older adults: A UK biobank study. Brain Imaging Behav. 2021; 15(6):2813-2823. PMC: 8761720. DOI: 10.1007/s11682-021-00548-y. View

13.

Vipin A, Ng K, Ji F, Shim H, Lim J, Pasternak O . Amyloid burden accelerates white matter degradation in cognitively normal elderly individuals. Hum Brain Mapp. 2019; 40(7):2065-2075. PMC: 6501192. DOI: 10.1002/hbm.24507. View

14.

Mokhber N, Shariatzadeh A, Avan A, Saber H, Babaei G, Chaimowitz G . Cerebral blood flow changes during aging process and in cognitive disorders: A review. Neuroradiol J. 2021; 34(4):300-307. PMC: 8447819. DOI: 10.1177/19714009211002778. View

15.

Fazlollahi A, Calamante F, Liang X, Bourgeat P, Raniga P, Dore V . Increased cerebral blood flow with increased amyloid burden in the preclinical phase of alzheimer's disease. J Magn Reson Imaging. 2019; 51(2):505-513. DOI: 10.1002/jmri.26810. View

16.

Moghbel M, Saboury B, Basu S, Metzler S, Torigian D, Langstrom B . Amyloid-β imaging with PET in Alzheimer's disease: is it feasible with current radiotracers and technologies?. Eur J Nucl Med Mol Imaging. 2011; 39(2):202-8. DOI: 10.1007/s00259-011-1960-4. View